Announcements Trials
Browse Landscape

Phase

Phase 3 1Phase 1 1

Status

Unknown 1Recruiting 1

Sponsor Class

OTHER 1INDUSTRY 1

Study Type

Interventional 2

Sponsor

Cancer Type

Gynecologic 2

Conditions

Ovarian Neoplasms 328Fallopian Tube Neoplasms 153Carcinoma, Ovarian Epithelial 115Endometrial Neoplasms 95Uterine Cervical Neoplasms 80Neoplasms 28Breast Neoplasms 27Peritoneal Neoplasms 24Brenner Tumor 24Carcinoma, Non-Small-Cell Lung 21Stomach Neoplasms 18Recurrence 17Neoplasm Metastasis 14Uterine Neoplasms 13Testicular Neoplasms 11Parkinson Disease 4, Autosomal Dominant Lewy Body 11Colorectal Neoplasms 11Squamous Cell Carcinoma of Head and Neck 10Lung Neoplasms 10Melanoma 9Testicular Germ Cell Tumor 8Central Nervous System Neoplasms 8Urinary Bladder Neoplasms 7Triple Negative Breast Neoplasms 7Esophageal Neoplasms 7Carcinoma 7Prostatic Neoplasms 6Pancreatic Neoplasms 6Neurotoxicity Syndromes 6Carcinosarcoma 6

Interventions

Paclitaxel 2Cisplatin 2Carboplatin 2toripalimab 1sintilimab 1camrelizumab 1anlotinib 1Capecitabine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Advanced Cervical Cancer × Paclitaxel × Gynecologic × Clear all
NCT07168200 2026-04-15

A Phase III Clinical Study of Adebrelimab Combined With Concurrent Chemoradiotherapy Versus Placebo Combined With Concurrent Chemoradiotherapy for the Treatment of Locally Advanced Cervical Cancer

Shanghai Shengdi Pharmaceutical Co., Ltd

Phase 3 Recruiting
720 enrolled
Gynecologic

Advanced Cervical Cancer

NCT04731038 2021-09-17

Combination Therapy for First Line Treatment of Advanced Cervical Cancer

Ruijin Hospital

Phase 1 Unknown
20 enrolled
Gynecologic

Advanced Cervical Cancer

Data powered by HemOnc (CC BY 4.0) Colophon âš¡